DETAILED NOTES ON SUVOREXANT

glycerol phenylbutyrate will reduce the extent or effect of triazolam by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch. Glycerol phenylbutyrate is actually a weak inducer of CYP3A4. Watch for diminished efficacy of CYP3A4 substrates that have a narrow therapeutic index.Equally outpatient reports along with a snooze labora